Carmen Chang

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carmen Chang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7,692,298 $146,153,662 $19.00 28 Jun 2021 Indirect
Savara Inc 10%+ Owner Common Stock 24,471,264 $108,897,125 $4.45 17 Jul 2023 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 1,090,793 $61,084,408 $56.00 22 Apr 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Common Stock 3,614,486 $38,638,855 $10.69 16 Sep 2024 Indirect
Coursera, Inc. Director Common Stock 2,205,883 $19,301,476 $8.75 21 May 2025 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants 3,000,000 $5,697,000 $1.90 11 Apr 2022 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 948,948 $1,916,875 $2.02 11 Apr 2022 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2,563,257 $1,204,731 $0.4700 22 Dec 2021 Indirect
Coursera, Inc. Director Common Stock 88,260 $772,275 $8.75 21 May 2025 Direct
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 135 $3,785 $28.04 13 Jun 2023 Direct
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 02 Oct 2025 Indirect
Trevi Therapeutics, Inc. 10%+ Owner 3.5-Year Common Stock Warrant 1,851,852 18 Oct 2021 Indirect
Trevi Therapeutics, Inc. 10%+ Owner 7-Year Common Stock Warrant 1,851,852 18 Oct 2021 Indirect
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 30 Nov 2022 Indirect
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 25 May 2022 Indirect
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 16 Sep 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 16 Sep 2024 Indirect
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 0 $28.04 13 Jun 2023 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2.00 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 $2.96 28 Jun 2021 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series A Convertible Perpetual Preferred Stock 0 02 Oct 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series B Convertible Perpetual Preferred Stock 0 02 Oct 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 02 Oct 2025 Indirect

Insider Reports Filed by Carmen Chang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NEUE NeueHealth, Inc. 02 Oct 2025 31 +$14.83 4 Director, 10%+ Owner 06 Oct 2025, 17:52
COUR Coursera, Inc. 21 May 2025 1 $0 4 Director 23 May 2025, 17:36
NEUE NeueHealth, Inc. 01 Oct 2024 3 $0 4 10%+ Owner 03 Oct 2024, 18:31
MBX MBX Biosciences, Inc. 16 Sep 2024 5 +$8,000,000 4 10%+ Owner 17 Sep 2024, 20:23
MBX MBX Biosciences, Inc. 12 Sep 2024 0 $0 3 10%+ Owner 12 Sep 2024, 19:26
COUR Coursera, Inc. 22 May 2024 1 $0 4 Director 24 May 2024, 18:02
KRRO Korro Bio, Inc. 22 Apr 2024 1 +$999,992 4 10%+ Owner 24 Apr 2024, 17:00
NEUE NeueHealth, Inc. 08 Apr 2024 3 $0 4 10%+ Owner 10 Apr 2024, 19:10
BHG Bright Health Group Inc. 19 Dec 2023 1 $0 4 10%+ Owner 21 Dec 2023, 16:57
FREQ Korro Bio, Inc. 03 Nov 2023 0 $0 3 10%+ Owner 07 Nov 2023, 21:28
BHG Bright Health Group Inc. 31 Oct 2023 1 $0 4 10%+ Owner 02 Nov 2023, 18:35
BHG Bright Health Group Inc. 15 Sep 2023 1 $0 4 10%+ Owner 19 Sep 2023, 19:20
BHG Bright Health Group Inc. 11 Aug 2023 1 $0 4 10%+ Owner 15 Aug 2023, 22:51
SVRA Savara Inc 17 Jul 2023 1 +$999,999 4 10%+ Owner 19 Jul 2023, 19:07
MIRM Mirum Pharmaceuticals, Inc. 13 Jun 2023 4 $0 4 10%+ Owner 15 Jun 2023, 16:29
COUR Coursera, Inc. 24 May 2023 1 $0 4 Director 26 May 2023, 17:35
COUR Coursera, Inc. 15 Mar 2023 1 -$14,497 4 Director 17 Mar 2023, 16:30
COUR Coursera, Inc. 15 Feb 2023 1 $0 4 Director 17 Feb 2023, 17:56
AKUS Akouos, Inc. 30 Nov 2022 1 $0 4 10%+ Owner 02 Dec 2022, 16:05
BHG Bright Health Group Inc. 17 Oct 2022 2 +$137,700,000 4 10%+ Owner 19 Oct 2022, 19:54
GNCA GENOCEA BIOSCIENCES, INC. 24 May 2022 2 -$750,662 4 10%+ Owner 26 May 2022, 18:21
COUR Coursera, Inc. 13 May 2022 1 $0 4 Director 16 May 2022, 20:11
TRVI Trevi Therapeutics, Inc. 11 Apr 2022 3 +$12,499,999 4 10%+ Owner 13 Apr 2022, 17:13
BHG Bright Health Group Inc. 03 Jan 2022 2 +$200,000,000 4 10%+ Owner 05 Jan 2022, 17:00
MTCR Metacrine, Inc. 10 Dec 2021 3 -$494,483 4 10%+ Owner 27 Dec 2021, 15:42
COUR Coursera, Inc. 01 Nov 2021 1 $0 4 Director 03 Nov 2021, 21:47
TRVI Trevi Therapeutics, Inc. 18 Oct 2021 3 $0 4 10%+ Owner 19 Oct 2021, 21:12
COUR Coursera, Inc. 12 Oct 2021 0 $0 3 Director 12 Oct 2021, 18:32
BHG Bright Health Group Inc. 28 Jun 2021 12 +$34,999,992 4 10%+ Owner 30 Jun 2021, 21:29
GLUE Monte Rosa Therapeutics, Inc. 28 Jun 2021 7 +$19,950,000 4 10%+ Owner 30 Jun 2021, 18:02
BHG Bright Health Group Inc. 24 Jun 2021 0 $0 3 10%+ Owner 24 Jun 2021, 21:24
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 10%+ Owner 23 Jun 2021, 21:05